Article
Prediction of a null response to pegylated interferon α-2b plus ribavirin in patients with high viral load genotype 1b hepatitis C.
Gut and liver - 1 Jul 2014
Wada Yuki, Tamai Hideyuki, Kawashima Akira, Shingaki Naoki, Mori Yoshiyuki, Kawaguchi Masanori, Moribata Kosaku, Deguchi Hisanobu, Ueda Kazuki, Inoue Izumi, Maekita Takao, Iguchi Mikitaka, Kato Jun, Ichinose Masao
Abstract excerpt
BACKGROUND/AIMS: The present study aimed to clarify whether virological response within 2 weeks after therapy initiation can predict a null response to pegylated interferon α-2b plus ribavirin therapy in patients with high viral load genotype 1b hepatitis C. METHODS: The participants consisted of 72 patients with high viral load genotype 1b. The dynamics of viral load within 2 weeks were measured. RESULTS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.